Concepedia

James F. Eggier

JF

Statistics

Publications

1

Citations

29

H-Index

1

Active since

1995

Affiliations

Pfizer (United States)(Current)

James F. Eggier is an author at Pfizer (United States) specializing in drug discovery, chemical biology, and molecular docking.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryChemical BiologyDrug DevelopmentNatural SciencesMolecular DockingMolecular Pharmacology

Publications per year

1995–1995

1

Publications

1

Discovery of micromolar PDE IV inhibitors that exhibit much reduced affinity for the [3H]rolipram binding site: 3-norbornyloxy-4-methoxyphenylmethylene oxindoles

Hiroko Masamune, John B. Cheng, Kelvin Cooper et al. · Bioorganic & Medicinal Chemistry Letters · 1995 · 29 citations

Molecular Pharmacology, 3-Norbornyloxy-4-methoxyphenylmethylene Oxindoles, Drug Target +9

1–1 of 1